Revvity, Inc. (RVTY)
NYSE: RVTY · IEX Real-Time Price · USD
108.28
+0.13 (0.12%)
Jul 22, 2024, 12:13 PM EDT - Market open
Revvity Employees
Revvity had 11,500 employees as of December 31, 2023. The number of employees decreased by 5,200 or -31.14% compared to the previous year.
Employees
11,500
Change (1Y)
-5,200
Growth (1Y)
-31.14%
Revenue / Employee
$237,011
Profits / Employee
$13,011
Market Cap
13.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
Dec 31, 2022 | 16,700 | 0 | - |
Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
Dec 31, 2019 | 13,000 | 500 | 4.00% |
Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
Dec 31, 2016 | 8,000 | 0 | - |
Dec 31, 2015 | 8,000 | 300 | 3.90% |
Dec 31, 2014 | 7,700 | 100 | 1.32% |
Dec 31, 2013 | 7,600 | 100 | 1.33% |
Dec 31, 2012 | 7,500 | 300 | 4.17% |
Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
Dec 31, 2009 | 8,200 | 300 | 3.80% |
Dec 31, 2008 | 7,900 | -800 | -9.20% |
Dec 31, 2007 | 8,700 | 200 | 2.35% |
Dec 31, 2006 | 8,500 | 500 | 6.25% |
Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
Dec 31, 2004 | 10,000 | 0 | - |
Dec 31, 2003 | 10,000 | -700 | -6.54% |
Dec 31, 2002 | 10,700 | -100 | -0.93% |
Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
Dec 31, 2000 | 12,500 | 500 | 4.17% |
Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
Dec 31, 1996 | 15,000 | 0 | - |
Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Viatris | 38,000 |
Dr. Reddy's Laboratories | 27,048 |
Medpace Holdings | 5,900 |
Natera | 3,293 |
Insulet | 3,000 |
Neurocrine Biosciences | 1,400 |
Sarepta Therapeutics | 1,314 |
RVTY News
- 13 days ago - Revvity To Hold Earnings Call on Monday, July 29, 2024 - Business Wire
- 7 weeks ago - Revvity to Present at Goldman Sachs Global Healthcare Conference - Business Wire
- 3 months ago - Revvity beats quarterly estimates on demand for diagnostic equipment - Reuters
- 3 months ago - Revvity Announces Financial Results for the First Quarter of 2024 - Business Wire
- 3 months ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 3 months ago - Revvity to Present at BofA Securities 2024 Health Care Conference - Business Wire
- 3 months ago - Revvity Unveils a New Era of Automated Tuberculosis Testing - Business Wire
- 3 months ago - Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners - Business Wire